Literature DB >> 11502163

Plasmacytoid monocytes/T cells: a dendritic cell lineage?

L Galibert1, C R Maliszewski, S Vandenabeele.   

Abstract

Plasmacytoid monocytes/T cells were first described in 1958, yet their origin and function have remained enigmatic. Recently a series of publications brought these cells to the forefront of immunological research. Indeed, plasmacytoid monocytes/T-cells contain natural type-I interferon producing cells and can differentiate in vitro into dendritic cells (DC). It has been proposed that plasmacytoid monocytes/T-cells represent a distinct lineage of cells whose fate it is to differentiate into dendritic cells. Herein we will review recent advances in our understanding of plasmacytoid monocytes/T cells and highlight arguments in favor or against this lineage hypothesis. We propose that plasmacytoid monocytes/T cells represent a composite group of both myeloid and lymphoid early-committed cells that are characterized by their ability to differentiate in vitro into DC. Copyright 2001 Academic Press.

Mesh:

Year:  2001        PMID: 11502163     DOI: 10.1006/smim.2001.0324

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  9 in total

1.  Porcine peripheral blood dendritic cells and natural interferon-producing cells.

Authors:  Artur Summerfield; Laurence Guzylack-Piriou; Alexander Schaub; Carlos P Carrasco; Valerie Tâche; Bernard Charley; Kenneth C McCullough
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

Review 2.  The plasmacytoid monocyte/interferon producing cells.

Authors:  Fabio Facchetti; William Vermi; David Mason; Marco Colonna
Journal:  Virchows Arch       Date:  2003-10-28       Impact factor: 4.064

Review 3.  The role of type I interferon production by dendritic cells in host defense.

Authors:  P Fitzgerald-Bocarsly; D Feng
Journal:  Biochimie       Date:  2007-05-08       Impact factor: 4.079

4.  Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells.

Authors:  Jean-Philippe Herbeuval; Andrew W Hardy; Adriano Boasso; Stephanie A Anderson; Matthew J Dolan; Michel Dy; Gene M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-20       Impact factor: 11.205

5.  A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma.

Authors:  Takahiro Maeda; Kenn Murata; Takuya Fukushima; Kazuyuki Sugahara; Kazuto Tsuruda; Masanobu Anami; Yasuyuki Onimaru; Kunihiro Tsukasaki; Masao Tomonaga; Ryouzou Moriuchi; Hiroo Hasegawa; Yasuaki Yamada; Shimeru Kamihira
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

6.  Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells.

Authors:  Jean-François Fonteneau; Marie Larsson; Anne-Sophie Beignon; Kelli McKenna; Ida Dasilva; Ali Amara; Yong-Jun Liu; Jeffrey D Lifson; Dan R Littman; Nina Bhardwaj
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells.

Authors:  Anne Krug; Ravi Veeraswamy; Andrew Pekosz; Osami Kanagawa; Emil R Unanue; Marco Colonna; Marina Cella
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

Review 8.  New mechanisms and pathways for monocyte recruitment.

Authors:  W A Muller
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

9.  The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12.

Authors:  Béatrice Vanbervliet; Nathalie Bendriss-Vermare; Catherine Massacrier; Bernhard Homey; Odette de Bouteiller; Francine Brière; Giorgio Trinchieri; Christophe Caux
Journal:  J Exp Med       Date:  2003-09-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.